The popularity of Viagra initially drove a period of growth for pharma, nevertheless recent developments present a uncertain outlook for investors. Lower-cost versions are eroding revenue, and persistent patent https://sidneysmqs099319.blogprodesign.com/62585044/sildenafil-and-pharma-a-risky-play